Characterization and cDNA cloning of phospholipase C-gamma, a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor)-activated tyrosine kinase
about
A phosphoinositide 3-kinase/phospholipase Cgamma1 pathway regulates fibroblast growth factor-induced capillary tube formationIdentification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transductionA tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1FGF-10 and its receptor exhibit bidirectional paracrine targeting to urothelial and smooth muscle cells in the lower urinary tractSubsets of epidermal growth factor receptors during activation and endocytosisIdentification of a murine TEF-1-related gene expressed after mitogenic stimulation of quiescent fibroblasts and during myogenic differentiation8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathwaysFibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transductionElevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomasOncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gammaHigh-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with Src homology 2 domainsAn analysis of vertebrate mRNA sequences: intimations of translational controlFibroblast growth factor signaling in the vasculatureA novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell typesPromiscuity of fibroblast growth factor receptorsCR16, a novel proline-rich protein expressed in rat brain neurons, binds to SH3 domains and is a MAP kinase substrateFibroblast growth factor receptors have different signaling and mitogenic potentialsPhosphorylation sites at the C-terminus of the platelet-derived growth factor receptor bind phospholipase C gamma 1src-homology 2 (SH2) domain ligation as an allosteric regulator: modulation of phosphoinositide-specific phospholipase C gamma 1 structure and activity.Solution structure of GAP SH3 domain by 1H NMR and spatial arrangement of essential Ras signaling-involved sequence.Refinement of the structure of human basic fibroblast growth factor at 1.6 A resolution and analysis of presumed heparin binding sites by selenate substitution.SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gamma.Action of phosphatidylinositol-specific phospholipase Cgamma1 on soluble and micellar substrates. Separating effects on catalysis from modulation of the surface.Fibroblast growth factor-2 (FGF-2) increases N-cadherin expression through protein kinase C and Src-kinase pathways in human calvaria osteoblasts.Cloning and characterization of a phospholipase gene from Erwinia chrysanthemi EC16.A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R.Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein.Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation.Structure, function, and phylogeny of [Arg8]vasotocin receptors from teleost fish and toadBone tissue engineering: recent advances and promising therapeutic agents.clr-1 encodes a receptor tyrosine phosphatase that negatively regulates an FGF receptor signaling pathway in Caenorhabditis elegans.Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders.Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue.Activation of the MAP kinase pathway by FGF-1 correlates with cell proliferation induction while activation of the Src pathway correlates with migration.Activation of alternate prosurvival pathways accounts for acquired sunitinib resistance in U87MG glioma xenografts.Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular HypertrophySelective phospholipase C activation.Structural diversity and binding of FGF receptors.Direct activation of phospholipase C-gamma by fibroblast growth factor receptor is not required for mesoderm induction in Xenopus animal caps.
P2860
Q22001538-1483AF0C-F666-42C9-B63F-1FE3826CCA89Q24308600-3B9B78C2-F619-44F5-80CF-9AEB336FE3EDQ24310428-84F6D38D-42B1-4EAE-9087-216372039C83Q24314647-8687D6D3-C817-428F-B4B0-D86E24931B95Q24317697-4CB4856E-E026-4BF1-A77F-A65674ADB117Q24320086-04B47AB3-44F7-46A4-A878-2E5284C4520FQ24548250-1C229B42-0B0B-4F23-B32D-B86ACAEC29D0Q24555661-E7774D7A-E07E-4B3A-AC4F-7077408B62BFQ24559979-2F0F3F55-FC2D-40A2-A3E4-4FA41DD97085Q24561375-2E16C95F-B969-4178-99AD-C7D003AC3A15Q24563877-DB212226-DD84-45BF-8679-274D3A1E8A6AQ24642530-4755E8A2-4277-4376-A38A-4EC4C54C2897Q27011668-7DD52F8B-FEAA-4817-BAB3-BB4EC53D4F83Q28115019-F8D8E10D-62DB-4847-B0BD-D126A4F502EBQ28214927-4E650B43-4B6B-4B7F-9358-586B531189B4Q28287171-F7C781A6-89BE-4842-8A38-802795F21DB3Q28566762-C8CAC004-D01E-406F-A74E-03D225AE56FEQ28609648-4FDDDEEF-A8D8-4C3A-B725-C8D136C7AC1EQ28645716-B9CD8775-C0C8-4F89-A351-A36F3520F1D0Q30193694-2A1DF51B-EEEB-4CB6-8AF8-BB1B171DB632Q30194458-94178FBF-C8CB-43EF-BE70-FF3445C56CF3Q30194894-53E8EBD5-5D09-4232-B8D0-EFBC7D5F8DB5Q30195496-4AF0BCCF-12DE-4A18-9EA9-BF492BE58C18Q31920638-E419109F-6ED3-47AB-A4F8-0BC95A3BCEA1Q31948333-F4908DD1-500F-4BF3-88C1-EAB3A9247A4BQ33207496-73D85FC2-26B2-4800-B987-B0E3985B2535Q33610352-D6D621D4-B361-47F2-99AA-0DB7350BECBAQ34087175-3C3B02ED-9105-4FDE-94CD-68916BEEF4F4Q34179681-08B01EE4-0F9E-4E1D-B606-0200B9A53528Q35043319-E2DEF2EC-B564-44AC-97E5-F68DFB6F34EEQ35144021-7234B352-1077-4A6A-B455-54516F8E7B84Q35200613-8A7BBCEB-BE40-4BFD-893E-5006D29C6FBAQ35787010-4EE68822-C632-4E32-90CE-F1CD64304DB6Q36223955-822C4975-B7A8-4AE7-A33C-0AFC03788F82Q36256032-9B051F96-6C33-41A0-A922-1B67BD91D700Q36335477-6E54A803-A347-4E79-8EC7-BA62737BC95BQ36348861-7057E729-E7A7-4D40-8A6D-0ADEBF136C9BQ36413881-AD52922B-5737-4991-A33E-61C00A3F8C09Q36463372-88B09238-290E-44D3-A194-B7DC17B29064Q36651889-0003C5AA-15FA-444F-A092-06AC7D151B65
P2860
Characterization and cDNA cloning of phospholipase C-gamma, a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor)-activated tyrosine kinase
description
1990 nî lūn-bûn
@nan
1990 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Characterization and cDNA clon ...... tor)-activated tyrosine kinase
@ast
Characterization and cDNA clon ...... tor)-activated tyrosine kinase
@en
Characterization and cDNA clon ...... tor)-activated tyrosine kinase
@nl
type
label
Characterization and cDNA clon ...... tor)-activated tyrosine kinase
@ast
Characterization and cDNA clon ...... tor)-activated tyrosine kinase
@en
Characterization and cDNA clon ...... tor)-activated tyrosine kinase
@nl
prefLabel
Characterization and cDNA clon ...... tor)-activated tyrosine kinase
@ast
Characterization and cDNA clon ...... tor)-activated tyrosine kinase
@en
Characterization and cDNA clon ...... tor)-activated tyrosine kinase
@nl
P2093
P2860
P356
P1476
Characterization and cDNA clon ...... tor)-activated tyrosine kinase
@en
P2093
A Zilberstein
C A Dionne
J Schlessinger
W H Burgess
P2860
P304
P356
10.1128/MCB.10.9.4770
P407
P577
1990-09-01T00:00:00Z